Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - levamisole hydrochloride; fenbendazole - oral solution/suspension - levamisole hydrochloride anthelmintic active 80.0 g/l; fenbendazole carbamate-benzimidazole active 50.0 g/l - parasiticides - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | hookworm - bunostomum spp. | intestinal threadworm - s. papillosus | large lungworm - dictyocaulus filaria | large mouthed bowel worm | nodule worm - o. columbianum | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | tapeworm - monieza expansa | thin necked intestinal worm | whipworm - trichuris ovis | hair worm | intestinal hair worm | small hair worm | teladorsagia

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - abamectin - oral solution/suspension - abamectin anthelmintic active 0.8 g/l - parasiticides - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | large lungworm - dictyocaulus filaria | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | thin necked intestinal worm | hair worm | intestinal hair worm | small hair worm | teladorsagia

Australien - engelska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wsd agribusiness pty ltd - levamisole hydrochloride - oral solution/suspension - levamisole hydrochloride anthelmintic active 80.0 g/l - parasiticides - cattle | lamb | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | hei - barber's pole worm - haemonchus placei | barber's pole worm-haemonchus contortus | black scour worm - trichostrongylus spp. | hookworm - bunostomum phlebotomum | hookworm - bunostomum spp. | intestinal threadworm - s. papillosus | large bowel worm - o. venulosum | large lungworm - dictyocaulus filaria | large mouthed bowel worm | lungworm - dictyocaulus viviparus | nodule worm - o. columbianum | nodule worm - oesophagostomum radiatum | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | thin necked intestinal worm | hair worm | intestinal hair worm | large lungworm | small hair worm | teladorsagia

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - lamivudine 10 mg/ml;   - oral solution - 10 mg/ml - active: lamivudine 10 mg/ml   excipient: banana flavour 59.256 ap0551 citric acid methyl hydroxybenzoate propyl hydroxybenzoate propylene glycol purified water sodium citrate dihydrate strawberry flavour 057883 ap0551 sucrose - 3tc in combination with other anti-retroviral agents is indicated for the treatment of hiv infected adults and children.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - furosemide 10 mg/ml; furosemide 10 mg/ml - oral solution - 10 mg/ml - active: furosemide 10 mg/ml excipient: butylated hydroxyanisole butylated hydroxytoluene ethanol glycerol methyl hydroxybenzoate orange flavour 987431 polysorbate 80 potassium sorbate quinoline yellow sodium hydroxide sorbitol water active: furosemide 10 mg/ml excipient: ethanol glycerol methyl hydroxybenzoate orange flavour propyl hydroxybenzoate purified water quinoline yellow sodium hydroxide sorbitol sunset yellow fcf - oedema lasix is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. lasix is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. lasix injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, lasix is indicated by the intravenous route. parenteral use should be replaced with oral lasix as soon as practical.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

janssen-cilag (new zealand) ltd - risperidone 1 mg/ml (r064766);  ;   - oral solution - 1 mg/ml - active: risperidone 1 mg/ml (r064766)     excipient: benzoic acid purified water sodium hydroxide as 1n solution, to ph 3.0 tartaric acid - risperdal is indicated for the treatment of schizophrenia and other psychotic disorders. these include first episode psychoses, acute schizophrenic exacerbations, chronic schizophrenia and other psychotic conditions, in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, suspiciousness), and/or negative symptoms (such as blunted effect, emotional and social withdrawal, poverty of speech) are prominent.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - baclofen, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

medsurge pharma pty ltd - baclofen, quantity: 0.05 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - baclofen solution for intrathecal injection is indicated in patients with severe chronic spasticity of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) or of cerebral origin who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - ramucirumab - solution for infusion - 10mg/1ml